Clinical Trial Update: Descemet Endothelial Thickness Comparison Trial II [Phase 3]

View source ↗

Summary

Sponsored by Stanford University, this Phase 3 trial called Descemet Endothelial Thickness Comparison Trial II is investigating treatment strategies for Fuchs e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fuchs Endothelial Corneal Dystrophy

Snippet

Sponsor: Stanford University | Conditions: Fuchs, Fuchs Dystrophy | Phase 3 | Status: RECRUITING